Abstract
AbstractA 29‐year‐old woman, with 15 years of poorly controlled type 1 diabetes and established diabetic autonomic diarrhoea, presented with worsening diarrhoea and diabetic ketoacidosis. Frequency of bowel opening was up to 40 times per 24 hours. Octreotide was started, rapidly decreasing bowel motion frequency. Due to previous intolerable side effects of rotten odour breath and flatus, she converted to once‐monthly subcutaneous lanreotide (Somatuline Autogel). Her diarrhoea remained controlled without any side effects, until her demise a year later from severe diabetic ketoacidosis.To our knowledge this is the first published report of the successful treatment of intractable diabetic autonomic diarrhoea by once‐monthly subcutaneous lanreotide. Copyright © 2009 John Wiley & Sons.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
